Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156375 | SCV000206093 | likely benign | not specified | 2014-03-21 | criteria provided, single submitter | clinical testing | Tyr1490Tyr in exon 31 of MYH6: This variant has not been reported in individuals with cardiomyopathy or in large population studies. It is not expected to have clinical significance because it does not alter an amino acid residue and is no t located within the splice consensus sequence. Tyr1490Tyr in exon 31 of MYH6 ( allele frequency = n/a) |
Ambry Genetics | RCV002326888 | SCV002636677 | likely benign | Cardiovascular phenotype | 2022-10-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV002515015 | SCV003273174 | likely benign | Hypertrophic cardiomyopathy 14 | 2023-07-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003895062 | SCV004714640 | likely benign | MYH6-related condition | 2020-09-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |